top of page

     INNOVATIVE APPROACH TO
                WOUND HEALING

HYPPP Therapy - Advanced Treatment for Chronic Wounds, Diabetic Ulcers, Burns and Scars

Following 15 years of research and development in the UK (University College London) and Germany (Technical University of Munich),  HYPPP® therapy is now available to patients in Greece & Cyprus as an advanced treatment for chronic wounds, diabetic ulcers, burns and post-operative wounds. The treatment comprises a unique composition of protein factors, generated through an innovative process that mimics natural wound repair outside the body, that is topically applied to the area of tissue damage in order to stimulate and accelerate repair and regeneration by improving local blood supply, tissue remodelling and skin epithelialization

Flag_of_the_United_Kingdom_(1-2).svg.png
Our Mission

We understand that living with chronic wounds, burns or scars can make life unbearable. That's why we believe in a personalized and multidisciplinary approach to treatment. Our values and principles emphasize the importance of connecting patients and doctors to achieve the best possible outcomes. We are committed to providing our patients with the best possible standard of care. Our team of experts specializes in the advanced treatment of wounds, burns and scars . HYPPP® Therapy is a clinically effective treatment for hard-to-heal wounds, which has the great advantage of being able to be carried out by patients and/or their carers at home. We are dedicated to patient education and continuous research and development for advancing the field of wound repair and skin regeneration.

 

  • Expert Diagnosis 

  • Comprehensive and Individualized Treatment

  • Patient Education for Home Wound Management

  • Continuous Research and Development

Three Friends Laughing
A Multidisciplinary Network of Expert Physician Specialists

All of our associated physicians understand and support the application of HYPPP® Therapy as a modern and effective solution for difficult wounds, which are not easily treatable with conventional approaches. Through our network of expert physicians, we offer comprehensive and individualized treatment for chronic wounds, diabetic ulcers and burns. Our team of medical specialists can provide a targeted diagnosis to patients, in all fields relating to chronic wound pathology, such as Vascular Medicine, Endocrinology, Plastic Surgery and Dermatology. We utilize an efficient cross-referal system, so that patients can be seen by the right doctor without unnecessary delay.

Range of Treatments

Advanced treatments for

chronic wounds, ulcers, burns and scars

HYPPP® therapy is an next-generation, skin regenerative treatment that is proven to be clinically effective towards the healing of hard-to-heal chronic wounds and ulcers, as well as a tissue remodelling therapy for scars and burns.

Chart & Stethoscope
Karyatides Business Center HERO-min.jpg

Clinical Centres of Excellence

Our clinical wound centres in Greece and Cyprus offer state-of-the Art facilities that combine diagnostic modalities, surgical treatment and advanced wound therapy. Beyond that, we collaborate with many clinical centers natiowide that offer specialized services targeted toward trauma therapy, including vascular surgery, orthopaedic surgery and podiatry.

Latest News //

Press Release in ETHNOS
Greece, Sept 14, 2023
In a new article published in the high profile newspaper ETHNOS, new research findings supporting the clinical effectiveness of HYPPP Therapy were reported, highlighting the innovative approach of the treatment as an alternative to traditional methods for chronic wound healing.

New Research Publication - Clinical Study
July 13, 2023
A new research case series report, published in the International Journal Organogenesis, entitled 'Full-thickness dermal wound regeneration using hypoxia preconditioned blood-derived growth factors: A case series' describes the successful application of HYPPP Therapy in large, difficult-to-heal wounds that developed due to post-operative complications. Read the Article

New Research Publication - In Vivo Study

January 14, 2022 A new research case series report, published in the International Journal Biomedicines, entitled 'Hypoxia Preconditioned Serum (HPS)-Hydrogel Can Accelerate Dermal Wound Healing in Mice-An In Vivo Pilot Study' describes the successful application of HYPPP Therapy in wounds induced in mice. Read the Article

New Research Publication - Ex Vivo Study

January 19, 2023 A new study, published in the International Journal of Molecular Sciense, entitled 'In Vitro Comparison of Lymphangiogenic Potential of Hypoxia Preconditioned Serum (HPS) and Platelet-Rich Plasma (PRP)' shows that HYPPP Therapy is more effective than conventional PRP in stimulating new lymphatic / blood vessels Read the Article

IJMS.PNG

New Research Work

June 06, 2024

With great honour Dr. E.Hadjipanayi was invited by the International Journal of Molecular Sciences to act as Guest Editor in the upcoming special issue focusing on the 'Effect of Stromal Microenvironment on Angiogenesis' , which will host high-impact original research by experts in the field of tissue repair and regeneration.

ΑΡΧΙΚΗ and 3 more pages - Personal - Microsoft​ Edge 6_4_2024 10_47_53 AM.png

Science 4 Life Award

2016, Frankfurt, Germany 

The research work supporting HYPPP therapy (project EmaCure) won the prestigious Science 4 Life Award 2016. The multidisciplinary team of scientists working at TUM University in Munich have developed an advanced treatment that provides an effective solution for chronic wounds.

mri_emacure.png

TUM IDEAward

2014, Munich, Germany 

Project EmaCure, which laid the foundation for the development of HYPPP therapy, won the TUM IDEAward 2014, as a novel treatment for hard-to-heal wounds that uses regenerative growth factors applied directly to the wound using a bioactive dressing, which reactivates the body’s own tissue repair mechanism.

Τιμητική Διάκριση στον δρα Έ_edited.jpg

German Biotechology Prize

2013, Stuttgart, Germany 

Dr E.Hadjipanayi and Prof. A.F.Schilling  are awarded the German Biotechnology Innovation Prize for their work on the EmaCure therapy, at the German Symposium for Biotechnology (Council of German BioRegions) in Stuttgart.

bottom of page